Siyuan Shen

发表

Overexpression of SHARPIN promotes tumor progression in ovarian cancer.

Jianxiang Cheng, Lei Hua, Zhiyuan Jiang, 2022, Experimental and molecular pathology.

Myeloid differentiation 2 deficiency attenuates AngII-induced arterial vascular oxidative stress, inflammation, and remodeling

G. Liang, Gaojun Wu, Weijian Huang, 2021, Aging.

TLR2 regulates angiotensin II-induced vascular remodeling and EndMT through NF-κB signaling

G. Liang, Gaojun Wu, X. Guan, 2020, Aging.

Tabersonine attenuates Angiotensin II-induced cardiac remodeling and dysfunction through targeting TAK1 and inhibiting TAK1-mediated cardiac inflammation.

N. Chattipakorn, Ruijie Chen, Zhe Wang, 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Title Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration

J. Sivak, Fupeng Ma, P. Tarsa, 2018 .

Discovery of Oral VEGFR-2 Inhibitors with Prolonged Ocular Retention That Are Efficacious in Models of Wet Age-Related Macular Degeneration.

J. Sivak, B. Jaffee, Fupeng Ma, 2015, Journal of medicinal chemistry.

Reliability of the mouse model of choroidal neovascularization induced by laser photocoagulation.

T. Dryja, B. Jaffee, Yubin Qiu, 2014, Investigative ophthalmology & visual science.

[MODEL ESTABLISHMENT, MRI AND PATHOLOGICAL FEATURES OF EARLY STEROID-INDUCED AVASCULAR NECROSIS OF FEMORAL HEAD IN RABBIT].

Jiying Chen, W. Chai, Haolan Lei, 2015, Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery.

Allosteric modulation of G protein-coupled receptor signaling

Wei Yan, Z. Shao, Siyuan Shen, 2023, Frontiers in Endocrinology.

Leonurine attenuates angiotensin II-induced cardiac injury and dysfunction via inhibiting MAPK and NF-κB pathway.

Gaojun Wu, Weixin Li, Wu Luo, 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration.

J. Sivak, B. Jaffee, Fupeng Ma, 2018, Journal of medicinal chemistry.

Lack of Involvement of CEP Adducts in TLR Activation and in Angiogenesis

B. Jaffee, R. Cepeda, Yubin Qiu, 2014, PLoS ONE.

Long-acting protein drugs for the treatment of ocular diseases

T. Dryja, B. Jaffee, C. Bigelow, 2017, Nature Communications.

Langerhans cell histiocytosis in adults: a case report and review of the literature

Yuan Lu, Siyuan Shen, Cui Lian, 2016, Oncotarget.

Amount of Mononuclear Phagocyte Infiltrate Does Not Predict Area of Experimental Choroidal Neovascularization (CNV)

B. Jaffee, J. Aranda, Yubin Qiu, 2018, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Association of lactate-to-albumin ratio with in-hospital and intensive care unit mortality in patients with intracerebral hemorrhage

Dongjie Wu, Siyuan Shen, D. Luo, 2023, Frontiers in neurology.

Costunolide Protects Myocardium From Ischemia Reperfusion Injury by Inhibiting Oxidative Stress Through Nrf2/Keap1 Pathway Activation

Weixin Li, Wu Luo, Chengyi Dai, 2023, Journal of cardiovascular pharmacology.